newsfilter
← Latest News
GlobeNewswire·

Lantheus to Present Florbetaben F 18 Data at CTAD 2025

BEDFORD, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the Company) (NASDAQ:LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease